VSRV yields 2000000.06% · PFE yields 6.13%● Live data
📍 VSRV pulled ahead of the other in Year 1
Combined, VSRV + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VSRV + PFE for your $10,000?
Voiceserve, Inc., through its subsidiaries, engages in developing, manufacturing, licensing, and supporting a range of voice over Internet protocol (VoIP) software products and services for various types of communication devices in Europe, North America, Asia, and internationally. It provides VoipSwitch, an Internet protocol telephony system offering services, such as device to phone technology, personal computer (PC) to phone/Web to phone features, calling cards, SMS/ANI/PIN/DID/WEB callback, DIDs' mapping, and call shops; Videoswitch, a video on demand platform for delivering online content to various screens ranging from smartphones and PCs to high definition home theatres; and Call-to-PBX, which offers voice, video, and mobile IP communications solutions for small-to-medium size businesses and residential customers. The company markets its products and services to VoIP wholesalers termination carriers, retail VoIP providers, Internet providers, including WiFi and WiMax operators, cable TV networks, GSM providers, telecom resellers, prepaid serve companies, and small-to-medium size companies. Voiceserve, Inc. was founded in 2002 and is based in Edgware, the United Kingdom.
Full VSRV Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.